Equine Sports Council

Controlled Medications Library

ESC MEDICATION CLASSIFICATIONClass A - Therapeutic

ESC Medication Library · Revision 2

← Medication library · Compare sanctioning bodies

Acetazolamide,
Diamox

Medication Facts

Performance enhancing
No
Total hours to clear
Not recorded
Frequently used
Not recorded
ESC ID
ACETAZ-0020
Trade names
Diamox
Drug type
Carbonic anhydrase inhibitor
Plasma half-life · hours
Not Published
Equine dosing
0.25–0.5 mg/kg
Cmax · peak plasma concentration
5-10 µg/mL
Tmax · time to peak plasma concentration
12
ESC concentration guidance
May not exceed 6% efficacy in plasma
Primary withdrawal · hours
12
Washout withdrawal · hours
0
ESC control type
A1 - Generally Controlled - Therapeutic
Medication report required
Generally not required, however understand exceptions.

Uses & side effects

Product-specific side effects await source review.

Drug interactions

Contraindications

Sanctioning-body comparison

Plasma only. Compare published competition guidance for this medication. ESC guidance remains in Medication Facts above. A dosing guideline, withdrawal recommendation and laboratory detection threshold are different measures.

Sources reviewed September 23, 2026. “Not verified” means a gap in this comparison, not zero tolerance or permission. Doses describe the cited rules; your veterinarian must determine treatment and withdrawal.

Published guidance by organization
OrganizationPublished dose & routePlasma concentrationWithdrawal / timingControl / penalty class
AQHA Show HorsesShow rules · 2026 handbook
Conditions & sources

N/H or H/H genotype required.

VIO405.8

Reviewed 2026-09-23

Up to 3 mg/lb per 24 h (3 g/1,000 lb); route not specified in cited rule.No numeric plasma maximum stated.No separate drug-specific stop time stated.Permitted only for DNA-confirmed HYPP-positive horses.
APHA Paint Show HorsesShow rules · 2026 Rule Book
Conditions & sources

N/H or H/H genotype required.

SC-085.A.9

Reviewed 2026-09-23

Up to 3 mg/lb per 24 h (3 g/1,000 lb); route not specified in cited rule.No numeric plasma maximum stated.No separate drug-specific stop time stated.Permitted only for DNA-confirmed HYPP-positive horses.
ARCI Model RulesRacing model · Rules 15 / UCG 20.0 / CTMS 4.2.1
Conditions & sources

An unverified entry is not permission to use this medication. Consult the linked current rules. ARCI model comparison only; no state-specific rule is substituted. Schedule timing is tied to its stated regimen and is not a clearance guarantee.

UCG 20.0 PDF p. 11

Reviewed 2026-09-23

Not verified for this medication.Not verified for this medication.Not verified for this medication.Drug Class 4 · Penalty Class C. No dosing permission is implied by classification.
USEFNational Therapeutic Substance Provisions · 2026 + July amendment
Conditions & sources

An unverified entry is not permission to use this medication. Consult the linked current rules.

Reviewed 2026-09-23

Not verified for this medication.Not verified for this medication.Not verified for this medication.Medication-specific control not yet verified.